{"name":"J. Uriach and Company","slug":"j-uriach-and-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"i.v. iron sucrose","genericName":"i.v. iron sucrose","slug":"i-v-iron-sucrose","indication":"Iron deficiency anemia in patients with chronic kidney disease on hemodialysis","status":"marketed"}]}],"pipeline":[{"name":"i.v. iron sucrose","genericName":"i.v. iron sucrose","slug":"i-v-iron-sucrose","phase":"marketed","mechanism":"Iron sucrose is a stable iron-carbohydrate complex that delivers iron directly into the bloodstream to replenish depleted iron stores and support hemoglobin synthesis.","indications":["Iron deficiency anemia in patients with chronic kidney disease on hemodialysis","Iron deficiency anemia in patients with chronic kidney disease not on dialysis","Iron deficiency anemia in patients with non-dialysis-dependent chronic kidney disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOOGtxRHNMU2R6UGh5MlNpb3ZyX1hHNGw0cDgtOHEwOGozdVRhUmNzbGd5VTRUVFhBVGFTaUpPRTFPbkV2TGRRM21POEJqakVkQ2diX2VKdHNJS3diY0FTOHZ5eW9JaW1RWExSVFpUQjBjM0pFSUo5Y1lWSmlxcWc1OHJTd0lGcTU4QktR?oc=5","date":"2024-05-17","type":"deal","source":"Iberian Lawyer","summary":"Grupo J. Uriach acquires the German group Pascoe: Advisors - Iberian Lawyer","headline":"Grupo J. Uriach acquires the German group Pascoe: Advisors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQdE1CWV9jeERGRl9xSGMwMHpXTnVscUJXVUNtNE12bk9vWjhJYVBvTUFjX1NMUXdtWWlGaTNfTmpzdFlqZFM3clg1NDRPQ1VxM0luXzR3dWhSQXp2VWVqSW5rTjV5a1A5T3p1cllZaU5nSWxLQmd0b0txZ001Qkt2NUZ3?oc=5","date":"2021-09-21","type":"pipeline","source":"Iberian Lawyer","summary":"GA_P advises Uriach on the sale of its B2B to MCH - Iberian Lawyer","headline":"GA_P advises Uriach on the sale of its B2B to MCH","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}